{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:53:00Z","timestamp":1791208380223,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Reduced bone mineral density (BMD) has been reported in survivors of childhood and young adult acute lymphoblastic leukaemia (ALL); however, data from cohorts treated with contemporary protocols and including matched controls remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Procedure<\/jats:title>\n                    <jats:p>In this population\u2010based matched cross\u2010sectional study, we used data from the Danish ALL\u2010STAR cohort, comprising ALL survivors diagnosed between 2008 and 2019 at 1\u201345 years of age and treated according to the NOPHO ALL2008 protocol, and age\u2010 and sex\u2010frequency matched controls. Participants were evaluated at least 1 year after completion of therapy and underwent dual\u2010energy x\u2010ray absorptiometry between 2019 and 2024. BMD was adjusted for sex, age and height and compared with that of matched controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 298 ALL survivors and 346 matched controls. Median age at follow\u2010up was 14.1 years, and the median time since diagnosis was 6.9 years. The greatest deficits in adjusted BMD were observed at hip sites, particularly among high\u2010risk\u2013treated survivors, with adjusted mean values of 91.2% (95% CI 88.2\u201394.4) at the femoral neck, 90.1% (95% CI 86.9\u201393.3) at the total hip, and 90.3% (95% CI 87.0\u201393.7) at the trochanter. Increasing time since diagnosis was associated with partial normalisation of BMD relative to controls in the standard\u2010 and intermediate\u2010risk groups, a pattern not observed among high\u2010risk\u2010treated survivors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Persistent BMD deficits among survivors treated with high\u2010risk regimens, without evidence of the partial normalisation observed in the standard\u2010 and intermediate\u2010risk groups, underscore the need for long\u2010term monitoring of skeletal health in this subgroup.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/1545-5017.70727","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:05:21Z","timestamp":1791205521000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone Mineral Density After Contemporary Treatment for Acute Lymphoblastic Leukaemia: A Matched Cross\u2010Sectional Study"],"prefix":"10.1002","author":[{"given":"Karen Schow","family":"Jensen","sequence":"first","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine Aarhus University Hospital  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Tiedemann","family":"Skipper","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine Aarhus University Hospital  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Holtum","family":"Birkeb\u00e6k","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine Aarhus University Hospital  Aarhus Denmark"},{"name":"Department of Clinical Medicine Aarhus University  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine Copenhagen University Hospital Rigshospitalet  Copenhagen Denmark"},{"name":"Department of Clinical Medicine University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Leth","family":"Frandsen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine Copenhagen University Hospital Rigshospitalet  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Langdahl","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine Aarhus University  Aarhus Denmark"},{"name":"Department of Endocrinology Aarhus University Hospital  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke Beck","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine University of Copenhagen  Copenhagen Denmark"},{"name":"Department of Paediatrics and Adolescent Medicine Copenhagen University Hospital, Herlev Hospital  Herlev Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger Roer","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Public Health Aarhus University  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"M\u00f8lgaard","sequence":"additional","affiliation":[{"name":"Department of Nutrition Exercise and Sports University of Copenhagen  Copenhagen Denmark"},{"name":"Paediatric Nutrition Unit Rigshospitalet  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv","family":"Andr\u00e9s\u2010Jensen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine Copenhagen University Hospital Rigshospitalet  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte Klug","family":"Albertsen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine Aarhus University Hospital  Aarhus Denmark"},{"name":"Department of Clinical Medicine Aarhus University  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/leu.2017.265","article-title":"Results of NOPHO ALL2008 Treatment for Patients Aged 1\u201345 Years With Acute Lymphoblastic Leukemia","volume":"32","author":"Toft N.","year":"2018","journal-title":"Leukemia"},{"key":"e_1_2_9_3_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002296","article-title":"Long\u2010Term Inpatient Disease Burden in the Adult Life After Childhood Cancer in Scandinavia (ALiCCS) Study: A Cohort Study of 21,297 Childhood Cancer Survivors","volume":"14","author":"Fine Licht S.","year":"2017","journal-title":"PLoS Medicine"},{"key":"e_1_2_9_4_1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/cam4.1057","article-title":"Risk and Associated Risk Factors of Hospitalization for Specific Health Problems Over Time in Childhood Cancer Survivors: A Medical Record Linkage Study","volume":"6","author":"Font\u2010Gonzalez A.","year":"2017","journal-title":"Cancer Medicine"},{"key":"e_1_2_9_5_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159518","article-title":"High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow\u2010Up Study Using Medical Record Linkage","volume":"11","author":"Sieswerda E.","year":"2016","journal-title":"PLoS One"},{"key":"e_1_2_9_6_1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/djz016","article-title":"Long\u2010Term Risk of Hospitalization among Five\u2010Year Survivors of Childhood Leukemia in the Nordic Countries","volume":"111","author":"S\u00f8rensen G. V.","year":"2019","journal-title":"Journal of the National Cancer Institute"},{"key":"e_1_2_9_7_1","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1016\/S2352-3026(19)30050-X","article-title":"The Changing Burden of Long\u2010Term Health Outcomes in Survivors of Childhood Acute Lymphoblastic Leukaemia: A Retrospective Analysis of the St Jude Lifetime Cohort Study","volume":"6","author":"Mulrooney D. A.","year":"2019","journal-title":"Lancet Haematology"},{"key":"e_1_2_9_8_1","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","article-title":"The Cumulative Burden of Surviving Childhood Cancer: An Initial Report From the St Jude Lifetime Cohort Study (SJLIFE)","volume":"390","author":"Bhakta N.","year":"2017","journal-title":"Lancet"},{"key":"e_1_2_9_9_1","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1182\/blood-2007-10-117150","article-title":"Twenty\u2010Five\u2010Year Follow\u2010Up Among Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study","volume":"111","author":"Mody R.","year":"2008","journal-title":"Blood"},{"key":"e_1_2_9_10_1","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic Health Conditions in Adult Survivors of Childhood Cancer","volume":"355","author":"Oeffinger K. C.","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_9_11_1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canep.2017.06.005","article-title":"Risk of Hospitalization Among Survivors of Childhood and Adolescent Acute Lymphoblastic Leukemia Compared to Siblings and a General Population Sample","volume":"49","author":"Ou J. Y.","year":"2017","journal-title":"Cancer Epidemiology"},{"key":"e_1_2_9_12_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049847","article-title":"Health Care Utilisation Following Childhood Acute Lymphoblastic Leukaemia: A Population\u2010Based Matched Cohort Study","volume":"11","author":"Jensen K. S.","year":"2021","journal-title":"BMJ Open"},{"key":"e_1_2_9_13_1","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31047","article-title":"Predictors of Low and Very Low Bone Mineral Density in Long\u2010Term Childhood Acute Lymphoblastic Leukemia Survivors: Toward Personalized Risk Prediction","volume":"71","author":"Nadeau G.","year":"2024","journal-title":"Pediatric Blood & Cancer"},{"key":"e_1_2_9_14_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/cncr.32512","article-title":"Severity of Reduced Bone Mineral Density and Risk of Fractures in Long\u2010Term Survivors of Childhood Leukemia and Lymphoma Undergoing Guideline\u2010Recommended Surveillance for Bone Health","volume":"126","author":"Bloomhardt H. M.","year":"2020","journal-title":"Cancer"},{"key":"e_1_2_9_15_1","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/cncr.23912","article-title":"Bone Mineral Density in Young Adult Survivors of Acute Lymphoblastic Leukemia","volume":"113","author":"Thomas I. H.","year":"2008","journal-title":"Cancer"},{"key":"e_1_2_9_16_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/pbc.20553","article-title":"Changes in Bone Mineral Density in Survivors of Childhood Acute Lymphoblastic Leukemia","volume":"46","author":"Kaste S. C.","year":"2006","journal-title":"Pediatric Blood & Cancer"},{"key":"e_1_2_9_17_1","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29218","article-title":"Bone Health in Long\u2010Term Survivors of Pediatric Acute Lymphoblastic Leukemia. An Assessment by Peripheral Quantitative Computed Tomography","volume":"68","author":"Barr R. D.","year":"2021","journal-title":"Pediatric Blood & Cancer"},{"key":"e_1_2_9_18_1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/jbmr.3447","article-title":"Bone Morbidity and Recovery in Children with Acute Lymphoblastic Leukemia: Results of a Six\u2010Year Prospective Cohort Study","volume":"33","author":"Ward L. M.","year":"2018","journal-title":"Journal of Bone and Mineral Research"},{"key":"e_1_2_9_19_1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cncr.31184","article-title":"Bone Mineral Density in Children With Acute Lymphoblastic Leukemia","volume":"124","author":"Inaba H.","year":"2018","journal-title":"Cancer"},{"key":"e_1_2_9_20_1","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/pbc.25010","article-title":"Bone Mineral Density Among Long\u2010Term Survivors of Childhood Acute Lymphoblastic Leukemia: Results From the St. Jude Lifetime Cohort Study","volume":"61","author":"Gurney J. G.","year":"2014","journal-title":"Pediatric Blood & Cancer"},{"key":"e_1_2_9_21_1","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1210\/jc.2012-2393","article-title":"Longitudinal Assessment of Bone Density and Structure in Childhood Survivors of Acute Lymphoblastic Leukemia Without Cranial Radiation","volume":"97","author":"Mostoufi\u2010Moab S.","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_9_22_1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1210\/jc.2004-1476","article-title":"Bone Mineral Density in Childhood Survivors of Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation","volume":"90","author":"Brennan B. M. D.","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2018.04.012","article-title":"Changes in Pediatric DXA Measures of Musculoskeletal Outcomes and Correlation With Quantitative CT Following Treatment of Acute Lymphoblastic Leukemia","volume":"112","author":"Mostoufi\u2010Moab S.","year":"2018","journal-title":"Bone"},{"key":"e_1_2_9_24_1","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/MPH.0b013e3181d32199","article-title":"Assessment of Bone Mineral Density and Risk Factors in Children Completing Treatment for Acute Lymphoblastic Leukemia","volume":"32","author":"Gunes A. M.","year":"2010","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"key":"e_1_2_9_25_1","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1542\/peds.2004-1838","article-title":"Improvement in Bone Mineral Density and Body Composition in Survivors of Childhood Acute Lymphoblastic Leukemia: A 1\u2010Year Prospective Study","volume":"116","author":"Marinovic D.","year":"2005","journal-title":"Pediatrics"},{"key":"e_1_2_9_26_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bone.2013.11.017","article-title":"Bone Mineral Density at Diagnosis Determines Fracture Rate in Children With Acute Lymphoblastic Leukemia Treated According to the DCOG\u2010ALL9 Protocol","volume":"59","author":"te Winkel M. L.","year":"2014","journal-title":"Bone"},{"key":"e_1_2_9_27_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045543","article-title":"National, Clinical Cohort Study of Late Effects Among Survivors of Acute Lymphoblastic Leukaemia: The ALL\u2010STAR Study Protocol","volume":"11","author":"Andr\u00e9s\u2010Jensen L.","year":"2021","journal-title":"BMJ Open"},{"key":"e_1_2_9_28_1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ejh.12097","article-title":"Risk Group Assignment Differs for Children and Adults 1\u201345 Yr With Acute Lymphoblastic Leukemia Treated by the NOPHO ALL\u20102008 Protocol","volume":"90","author":"Toft N.","year":"2013","journal-title":"European Journal of Haematology"},{"key":"e_1_2_9_29_1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies","volume":"61","author":"Elm E.","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"e_1_2_9_30_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12891-024-07184-9","article-title":"Comparison of the Prevalence of Osteoporosis in People With Spinal Cord Injury According to Bone Mineral Density Reference Values for the Diagnosis of Osteoporosis: A Retrospective, Cross\u2010Sectional Study","volume":"25","author":"Lim J.","year":"2024","journal-title":"BMC Musculoskeletal Disorders"},{"key":"e_1_2_9_31_1","unstructured":"W.KE Practical considerations when replacing a DXA systemBedford:Hologic Inc(2011)."},{"key":"e_1_2_9_32_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an International Community of Software Platform Partners","volume":"95","author":"Harris P. A.","year":"2019","journal-title":"Journal of Biomedical Informatics"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2013A Metadata\u2010Driven Methodology and Workflow Process for Providing Translational Research Informatics Support","volume":"42","author":"Harris P. A.","year":"2009","journal-title":"Journal of Biomedical Informatics"},{"key":"e_1_2_9_34_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jposna.2024.100031","article-title":"Understanding the Importance of Peak Bone Mass","volume":"7","author":"Hereford T.","year":"2024","journal-title":"Journal of the Pediatric Orthopaedic Society of North America"},{"key":"e_1_2_9_35_1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","article-title":"Bone Density at Various Sites for Prediction of Hip Fractures. The Study of Osteoporotic Fractures Research Group","volume":"341","author":"Cummings S.","year":"1993","journal-title":"Lancet"},{"key":"e_1_2_9_36_1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s001980070020","article-title":"Peak Bone Mass","volume":"11","author":"Heaney R. P.","year":"2000","journal-title":"Osteoporosis International"},{"key":"e_1_2_9_37_1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00198-025-07458-5","article-title":"Bone Mineral Density in Childhood Cancer Survivors During and After Oncological Treatment: A Systematic Review and Meta\u2010Analysis","volume":"36","author":"Markarian A. M.","year":"2025","journal-title":"Osteoporosis International"},{"key":"e_1_2_9_38_1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/adc.2009.172528","article-title":"Skeletal Morbidity in Children Receiving Chemotherapy for Acute Lymphoblastic Leukaemia","volume":"95","author":"Elmantaser M.","year":"2010","journal-title":"Archives of Disease in Childhood"},{"key":"e_1_2_9_39_1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54069","article-title":"Attributable Risk and Consequences of Bone Mineral Density Deficits in Childhood Cancer Survivors","volume":"8","author":"Goodenough C. G.","year":"2025","journal-title":"JAMA Network Open"},{"key":"e_1_2_9_40_1","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone Quality\u2013The Material and Structural Basis of Bone Strength and Fragility","volume":"354","author":"Seeman E.","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_9_41_1","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height Adjustment in Assessing Dual Energy X\u2010Ray Absorptiometry Measurements of Bone Mass and Density in Children","volume":"95","author":"Zemel B. S.","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_9_42_1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jpeds.2006.11.036","article-title":"Decreased Adult Height in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study","volume":"150","author":"Chow E. J.","year":"2007","journal-title":"Journal of Pediatrics"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1545-5017.70727","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/1545-5017.70727","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1545-5017.70727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:05:26Z","timestamp":1791205526000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/1545-5017.70727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":41,"alternative-id":["10.1002\/1545-5017.70727"],"URL":"https:\/\/doi.org\/10.1002\/1545-5017.70727","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"2026-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70727"}}